KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.03 $5.34 Friday, 26th Apr 2024 BCRX stock ended at $4.16. During the day the stock fluctuated 3.40% from a day low at $4.12 to a day high of $4.26.
90 days $4.03 $6.35
52 weeks $4.03 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Mar 07, 2016 $2.98 $3.24 $2.85 $2.98 4 897 900
Mar 04, 2016 $2.62 $2.85 $2.54 $2.58 2 149 300
Mar 03, 2016 $2.50 $2.90 $2.48 $2.61 3 673 700
Mar 02, 2016 $2.11 $2.57 $2.09 $2.51 2 230 000
Mar 01, 2016 $2.01 $2.13 $1.95 $2.13 2 739 500
Feb 29, 2016 $2.19 $2.20 $1.89 $1.99 1 908 500
Feb 26, 2016 $2.03 $2.28 $1.96 $2.21 1 176 500
Feb 25, 2016 $1.85 $2.04 $1.81 $1.98 1 143 000
Feb 24, 2016 $1.82 $1.95 $1.74 $1.90 1 638 900
Feb 23, 2016 $2.02 $2.14 $1.89 $1.90 1 069 000
Feb 22, 2016 $2.09 $2.20 $2.09 $2.16 1 310 800
Feb 19, 2016 $2.04 $2.11 $2.00 $2.06 1 052 900
Feb 18, 2016 $2.25 $2.27 $2.02 $2.04 1 544 900
Feb 17, 2016 $1.95 $2.21 $1.81 $2.17 2 368 700
Feb 16, 2016 $1.78 $1.95 $1.76 $1.86 1 968 400
Feb 12, 2016 $1.71 $1.74 $1.63 $1.71 1 823 600
Feb 11, 2016 $1.75 $1.75 $1.64 $1.66 2 138 900
Feb 10, 2016 $1.84 $1.99 $1.78 $1.80 1 838 500
Feb 09, 2016 $1.79 $2.09 $1.78 $1.89 4 916 200
Feb 08, 2016 $2.40 $2.43 $1.76 $1.78 9 294 300
Feb 05, 2016 $6.62 $6.75 $6.09 $6.14 1 322 300
Feb 04, 2016 $6.49 $6.95 $6.40 $6.50 939 400
Feb 03, 2016 $6.54 $6.72 $6.20 $6.53 661 000
Feb 02, 2016 $6.80 $6.85 $6.44 $6.51 793 300
Feb 01, 2016 $6.94 $7.09 $6.65 $6.90 824 200
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT